Nesfatin-1: A Biomarker and Potential Therapeutic Target in Neurological Disorders

Neurochem Res. 2023 Sep 23. doi: 10.1007/s11064-023-04037-0. Online ahead of print.ABSTRACTNesfatin-1 is a novel adipocytokine consisting of 82 amino acids with anorexic and anti-hyperglycemic properties. Further studies of nesfatin-1 have shown it to be closely associated with neurological disorders. Changes in nesfatin-1 levels are closely linked to the onset, progression and severity of neurological disorders. Nesfatin-1 may affect the development of neurological disorders and can indicate disease evolution and prognosis, thus informing the choice of treatment options. In addition, regulation of the expression or level of nesfatin-1 can improve the level of neuroinflammation, apoptosis, oxidative damage and other indicators. It is demonstrated that nesfatin-1 is involved in neuroprotection and may be a therapeutic target for neurological disorders. In this paper, we will also discuss the role of nesfatin-1 as a biomarker in neurological diseases and its potential mechanism of action in neurological diseases, providing new ideas for the diagnosis and treatment of neurological diseases.PMID:37740893 | DOI:10.1007/s11064-023-04037-0

Source: Neurochemical Research - September 23, 2023 Category: Neuroscience Authors: Siyu Zhou Jianfei Nao Source Type: research